D07.5 Carcinoma in situ of prostate

Name of the Condition

• Carcinoma in situ of prostate
• Also known as non-invasive cancer of the prostate lining.

Summary

Carcinoma in situ of the prostate refers to early-stage, non-invasive tumors confined to the lining cells of the prostate gland. The abnormal cells have not invaded deeper tissues or spread to other parts of the body, but they have the potential to progress to invasive cancer if left untreated.

Causes

The exact causes of carcinoma in situ in the prostate are not fully understood, but they may involve DNA mutations in the lining cells. Prolonged exposure to carcinogens and chronic irritation are believed to contribute to the development of these lesions.

Risk Factors

• Age (more common in older adults)
• Family history of prostate cancer
• Genetic mutations (e.g., BRCA1/2)
• Chronic inflammation
• Hormonal imbalances

Symptoms

• Often asymptomatic in early stages
• Difficulty urinating
• Frequent urination
• Blood in urine or semen
• Pelvic discomfort

Diagnosis

Diagnosis typically involves prostate-specific antigen (PSA) testing, followed by biopsy to examine tissue samples for atypical cells. Imaging studies such as MRI may be used to assess the prostate if invasive cancer is suspected.

Treatment Options

Treatment options may include active surveillance, surgery, or radiation therapy, depending on the extent of the lesion and patient factors.

Prognosis and Follow-Up

Prognosis is generally favorable with early detection and appropriate management. Regular follow-up with PSA testing and imaging is recommended to monitor for progression.

Complications

If left untreated, carcinoma in situ may progress to invasive prostate cancer, which can spread to surrounding tissues or other parts of the body.

Lifestyle & Prevention

• Maintain a healthy diet rich in fruits and vegetables
• Exercise regularly
• Avoid tobacco and excessive alcohol
• Discuss screening with a healthcare provider based on risk factors

When to Seek Professional Help

Seek medical attention if you experience persistent urinary symptoms, blood in urine or semen, or pelvic discomfort.

Tips for Medical Coders

When coding D07.5, ensure documentation supports the diagnosis of carcinoma in situ confined to the prostate lining. Verify that invasive cancer is not present, as this would require a different code. Document any biopsies, imaging, or treatment plans to support the code assignment.